Search results
2 kwi 2024 · Universal vaccination: To reduce community transmission and protect individuals with HIV, this committee agrees with the CDC recommendations for universal vaccination against COVID-19 for adults (≥18 years old) with HIV, regardless of prior history of COVID-19 infection.
2 wrz 2024 · Longer-term solutions are in the works. But how close are we to a cure for HIV — or a vaccine? Nature spoke with specialists to find out. What advances have been made in the treatment of HIV?
21 lis 2021 · Now, 40 years after the first report of the disease now known as AIDS, proof that an HIV vaccine is possible, has relied heavily on active and passive vaccine studies in non‐human primates (NHP), the RV144 phase 2b trial in Thailand, and studies of passively administered monoclonal antibodies in NHP and, more recently, humans [ 5, 6, 7, 8] The s...
22 gru 2022 · Vaccination is most effective in patients with early HIV infection and in those on ART who are virologically suppressed and have restored CD4 function. This topic will review the approach to vaccination for vaccine-preventable diseases in persons with HIV.
6 mar 2024 · Health news. After decades of failures, researchers have renewed hopes for an effective HIV vaccine. Favorable preliminary results from two HIV vaccine studies were presented at a...
17 maj 2024 · A trial vaccine has succeeded in generating low levels of antibodies needed to target HIV. It’s a first but much-needed step toward preventing infection.
10 sty 2024 · For people with HIV without risk factors, waiting for a CD4 count >200 cells/mm 3 is an option. Assess antibody response 1 to 2 months after completion of the series. If negative, revaccinate when the CD4 count is >200 cells/mm 3 (BIII).
